SGLT2 Inhibitors and Their Antiarrhythmic Properties

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are gaining ground as standard therapy for heart failure with a class-I recommendation in the recently updated heart failure guidelines from the European Society of Cardiology. Different gliflozins have shown impressive beneficial effects in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolesnik, Ewald, Scherr, Daniel, Rohrer, Ursula, Benedikt, Martin, Manninger, Martin, Sourij, Harald, von Lewinski, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835896/
https://www.ncbi.nlm.nih.gov/pubmed/35163599
http://dx.doi.org/10.3390/ijms23031678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835896/
https://www.ncbi.nlm.nih.gov/pubmed/35163599
http://dx.doi.org/10.3390/ijms23031678

Ejemplares similares